RSCM
NXTM

Rail-Splitter Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Rail-Splitter Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-351,374
Closed -$4.62M – 44
2013
Q3 		$4.62M Sell
351,374
-95,816
-21% -$1.26M 1.97% 29
2013
Q2 		$6.39M Buy
+447,190
New +$5.62M 2.82% 12

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return

Rail-Splitter Capital Management's NXTM Position: Q4 2013 in Review

Rail-Splitter Capital Management sold out of NxStage Medical Inc. (NXTM) in Q4 2013, closing a stake of 351,374 shares — an estimated $4.62M sold.

Rail-Splitter Capital Management first reported a position in NXTM in Q2 2013 and held it in 2 quarters. The position peaked at $6.39M in Q2 2013. 114 funds tracked by Wall St. Rank hold NXTM as of Q4 2013.

  • Rail-Splitter Capital Management reported no remaining NxStage Medical Inc. position as of Q4 2013 after selling out during the quarter.
  • Rail-Splitter Capital Management sold 351,374 NxStage Medical Inc. shares in Q4 2013, an estimated $4.62M.
  • Rail-Splitter Capital Management first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 2 quarters.
  • Rail-Splitter Capital Management's NxStage Medical Inc. position peaked at $6.39M in Q2 2013.
  • 114 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2013.

Based on Rail-Splitter Capital Management's 13F filing for Q4 2013, filed 30 Jan 2014.